Bicara Therapeutics Inc. Earnings Per Share (Basic)
Bicara Therapeutics Inc. (BCAX) reported Earnings Per Share (Basic) of -$0.82 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Bicara Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.82.
- Bicara Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.93.
- Bicara Therapeutics Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.00.
- Bicara Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.67.
- Bicara Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$2.52.
- Bicara Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$4.05.
- Bicara Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$89.61.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.82 10-Q · filed 2026-08-11 | -$1.73 10-Q · filed 2026-08-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.93 10-Q · filed 2026-05-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$2.52 10-K · filed 2026-03-30 |
| 2025-09-30 | -$0.67 10-Q · filed 2025-11-10 | -$1.17 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.84 10-Q · filed 2025-11-10 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.50 10-Q · filed 2026-08-11 | -$1.18 10-Q · filed 2026-08-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.68 10-Q · filed 2026-05-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$0.01 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2024-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$4.05 10-K · filed 2026-03-30 |
| 2024-09-30 | -$1.60 10-Q · filed 2025-11-10 | -$5.85 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$11.27 10-Q · filed 2025-11-10 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-11-10 |
| 2024-06-30 | -$19.01 10-Q · filed 2025-08-12 | -$38.19 10-Q · filed 2025-08-12 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-11-10 |
| 2024-03-31 | -$18.94 10-Q · filed 2025-05-13 | -$0.02 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-11-10 | |
| 2023-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.03 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$89.61 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$38.23 10-Q · filed 2024-11-12 | -$70.18 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |